valsartan and hydrochlorothiazide 160 mg; 25 mg Tablet, Film Coated, 90-count — NDC 70771-1487-9 (Billing 70771-1487-09)
This is a package of 90 tablets of valsartan and hydrochlorothiazide 160 mg; 25 mg Tablet, Film Coated from Zydus Lifesciences Limited, marketed since Feb 2020 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 70771-1487-9 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 70771 labeler · 1487 product · 9 package
- Package marketed since
- Feb 12, 2020
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC)
- 0370771148905
- FDA record last changed
- Oct 1, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 200284
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 5, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Thiazide Diuretic class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
- This tablet combines two different blood pressure-lowering medicines in one pill: valsartan, which relaxes your blood vessels, and hydrochlorothiazide, a water pill that helps your...
- What exactly is this medication and why did my doctor prescribe it?
- You can take it either way — with or without food. The hydrochlorothiazide part isn't affected by food at all. Food does reduce how much valsartan your body absorbs, but since you...
- Does it matter if I take it with food or on an empty stomach?
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 5, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $0.3156 | $28.40 / 90 tablets |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 5, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 70771-1487-00 70771-1487-0 Main listing | 1000 TABLET, FILM COATED in 1 BOTTLE | 2020-02-12 | — | Active |
| 70771-1487-04 70771-1487-4 | 10 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK | 2020-02-12 | — | Active |
| 70771-1487-09 You're viewing this | 90 TABLET, FILM COATED in 1 BOTTLE | 2020-02-12 | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 70771-1487-00?
What NDC number is used to bill for this package of valsartan and hydrochlorothiazide 160 mg; 25 mg Tablet, Film Coated?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 00378-6323-77 | Mylan | 90 tablets | $0.121 | AB | Availability likely | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 33342-0076-10 | Macleods | 90 tablets | $0.121 | AB | Availability likely | — |
| Diovan HCT 160 mg/1; 25 mg 00078-0383-34 | Novartis | 90 tablets | $13.047 | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 42291-0967-90 | AvKARE | 90 tablets | — | AB | FDA listed | — |
| Valsartan And Hydrochlorothiazide 160 mg/1; 25 mg 43547-0313-03 | Solco | 30 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 46708-0455-10 | Alembic | 100 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 50090-4872-00 | A-S | 90 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 50090-5985-00 | A-S | 90 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 50090-6210-00 | A-S | 90 tablets | — | AB | FDA listed | — |
| Valsartan And Hydrochlorothiazide 160 mg/1; 25 mg 50090-7444-00 | A-S | 90 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 53746-0847-90 | Amneal | 90 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 62332-0081-10 | Alembic | 100 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 65162-0847-03 | Amneal | 30 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 65862-0549-10 | Aurobindo | 10 tablets | — | — | FDA listed | — |
| valsartan and hydrochlorothiazide 160 mg/1; 25 mgthis 70771-1487-09 | Zydus | 90 tablets | — | — | FDA listed | — |
| Valsartan And Hydrochlorothiazide 160 mg/1; 25 mg 71335-2633-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Valsartan and Hydrochlorothiazide 160 mg/1; 25 mg 82868-0054-30 | Northwind | 30 tablets | — | AB | FDA listed | — |
| Valsartan And Hydrochlorothiazide 160 mg/1; 25 mg 50228-0149-10 | ScieGen | 1000 tablets | — | AB | FDA listed | — |
| Valsartan And Hydrochlorothiazide 160 mg/1; 25 mg 84677-0074-90 | Golden | 90 tablets | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Oct 5, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Valsartan and Hydrochlorothiazide inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII L11K75P92J
A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII 2S7830E561
Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
-
UNII 1K09F3G675
Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
-
UNII EX438O2MRT
Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
-
UNII XM0M87F357
A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
-
UNII 3NXW29V3WO
Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 4R4HFI6D95
Polyethylene glycol 4000 is a synthetic polymer derived from petroleum. It serves as a binder, filler, and lubricant in solid dosage forms, and helps control how quickly the medicine dissolves.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 7SEV7J4R1U
A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
-
UNII 15FIX9V2JP
Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
12 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 5, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Zydus Lifesciences Limited labeler code 70771
- Tadalafil 2.5 mg Tablet, Film Coated NDC 70771-1475-0
- Tadalafil 5 mg Tablet, Film Coated NDC 70771-1476-0
- Tadalafil 10 mg Tablet, Film Coated NDC 70771-1477-0
- Tadalafil 20 mg Tablet, Film Coated NDC 70771-1478-0
- valsartan and hydrochlorothiazide 80 mg; 12.5 mg Tablet, Film Coated NDC 70771-1485-0
- valsartan and hydrochlorothiazide 160 mg; 12.5 mg Tablet, Film Coated NDC 70771-1486-0
- valsartan and hydrochlorothiazide 320 mg; 12.5 mg Tablet, Film Coated NDC 70771-1488-0
- valsartan and hydrochlorothiazide 320 mg; 25 mg Tablet, Film Coated NDC 70771-1489-0
- leflunomide 10 mg Tablet, Film Coated NDC 70771-1491-1
- leflunomide 20 mg Tablet, Film Coated NDC 70771-1492-1
- esomeprazole magnesium 20 mg Capsule, Delayed Release NDC 70771-1493-0
- esomeprazole magnesium 40 mg Capsule, Delayed Release NDC 70771-1494-0
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 Package Label / Principal Display Panel ▾
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Valsartan and Hydrochlorothiazide Tablets USP, 80/12.5 mg NDC 70771-1485-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 160/12.5 mg NDC 70771-1486-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 160/25 mg NDC 70771-1487-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 320/12.5 mg NDC 70771-1488-0 in bottle of 1000 tablets 1000 tablets Rx only Valsartan and Hydrochlorothiazide Tablets USP, 320/25 mg NDC 70771-1489-0 in bottle of 1000 tablets 1000 tablets Rx only 80 mg/ 12.5 mg 160 mg/ 12.5 mg 160 mg/ 25 mg 320 mg/ 12.5 mg 320 mg/ 25 mg
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |